Zymeworks, Inc. (ZYME)
24.42
+0.49
(+2.05%)
USD |
NASDAQ |
May 18, 16:00
25.00
+0.58
(+2.38%)
After-Hours: 20:00
Zymeworks Total Liabilities (Quarterly) : 314.63M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 120.24M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Catalyst Pharmaceuticals, Inc. | 134.91M |
| Vertex Pharmaceuticals, Inc. | 7.122B |
| AbbVie, Inc. | 143.08B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 478.22M |
| Shareholders Equity (Quarterly) | 163.59M |
| Debt to Equity Ratio | 1.611 |
| Current Ratio | 10.82 |
| Net Debt Paydown Yield | -2.66% |